WOMEN taking hormone replacement therapy (HRT) to manage symptoms of menopause may increase their risk of blood clots, according to a new study released by University of Nottingham researchers in the UK.
The study looked at the prescription records of 80,000 women aged 40-79 who had developed blood clots and compared them with records of 390,000 women who had not.
The risk of blood clots was 15% higher for the treatments containing oestrogen manufactured from horse urine than for the synthetic oestradiol; in real terms, an additional nine cases per 10,000 women per year.
Those using gels, patches or creams (transdermal delivery forms) appeared to have no increased risk of blood-clotting.
More research is needed to confirm a causative association, scientists wrote - see bbc.com.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jan 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jan 19
